SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)

Core Viewpoint - A securities class action lawsuit has been filed against Boston Scientific Corporation on behalf of investors who purchased its common stock between July 23, 2025, and February 3, 2026, alleging violations of the Securities Exchange Act of 1934 [1][5]. Group 1: Lawsuit Details - The lawsuit was filed in the United States District Court for the District of Massachusetts, claiming that Boston Scientific and certain senior officers made misrepresentations regarding the company's U.S. electrophysiology segment [5]. - Investors are encouraged to join the class action and can contact the Investor Relations Manager for more information [3][8]. Group 2: Legal Process - Individuals wishing to serve as lead plaintiff must file necessary documents by May 4, 2026, although participation as a class member does not require serving as lead plaintiff [4]. - All legal representation is on a contingency fee basis, meaning shareholders will not incur fees or expenses unless there is a recovery [4]. Group 3: Firm Background - Bernstein Liebhard LLP, the law firm handling the case, has recovered over $3.5 billion for clients since its establishment in 1993 and has a strong track record in class action litigation [6].